je.st
news
Home
› Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies
Zyoxel Announces The Performance Of Tests By Sanofi On The Power Of 3D Liver Culture Models For More Predictive And Insightful DMPK Studies
2013-12-04 06:22:33| drugdiscoveryonline News Articles
Zyoxel, the world’s leading expert for advanced in vitro 3D liver models for drug discovery and drug testing, has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies
Tags: power
performance
culture
studies
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||